Polysaccharides that improve the water-holding capacity of dairy products
Streptococcus thermophilus strains DSM33981 and DSM33982 produce extracellular polysaccharides with an eps gene cluster, addressing the challenge of high water retention and low viscosity in cheese production, enhancing yield and reducing whey separation.
Patent Information
- Application Number
- JP2024531032
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2021-11-25
- Filing Date
- 2022-11-23
- Publication Date
- 2024-11-15
AI Technical Summary
Existing dairy starter cultures struggle to achieve a balance of high water-holding capacity and low viscosity, which is crucial for efficient cheese production, as high viscosity leads to problematic whey separation and longer fermentation times.
Identification and development of bacterial strains, specifically Streptococcus thermophilus strains DSM33981 and DSM33982, that produce extracellular polysaccharides with a unique eps gene cluster, enabling high water retention and low shear stress, facilitating faster acidification and improved cheese yield.
The identified strains enhance water retention capacity and reduce shear stress, leading to increased cheese yield and reduced whey separation, thus improving production efficiency and sustainability.
Smart Images

Figure 2024542531000001_ABST
Abstract
Description
[Technical field]
[0001] The present invention relates to novel exopolysaccharides and bacterial strains producing such polysaccharides that improve the water-holding capacity of dairy products. These polysaccharides and strains also allow the retention of desirable shear stress properties and acidification times that are difficult to combine with high water-holding capacity. [Background technology]
[0002] Dairy companies are constantly looking for ways to optimize production: investing in energy optimization, changing the product mix, making better use of waste, etc. One of the solutions to increase product yield, i.e. getting more product from a given amount of milk, is to use starter cultures that are able to retain more moisture in the cheese.
[0003] Increased water-holding capacity has benefits such as allowing cheese makers to produce more cheese from the same amount of milk and reducing the carbon footprint of their products. As a result, cheese production becomes more sustainable and customers save costs and their carbon footprint. Thus, increased water-holding capacity reduces syneresis in fermented dairy products and improves cheese yields. On an industrial scale, even relatively small improvements in water-holding capacity can lead to large savings in both financial and environmental costs.
[0004] The use of polysaccharide-producing starter cultures helps to increase the water-holding capacity of fermented milk, leading to reduced levels of whey separation in yogurt and increased moisture content and yield in cheese (Amatayakul et al., 2006).
[0005] As a result, there is an urgent need in the industry for polysaccharides and strains producing such polysaccharides that provide high water holding capacity while at the same time meeting all other relevant criteria for a commercially useful strain such as texture and acidification rate.
[0006] Polysaccharide structures (identified by repeating units) are extremely diverse, determined by the sugar building blocks, anomeric composition, glycosidic linkages, non-sugar modifications of the monosaccharides, and conformation.
[0007] The selection of suitable polysaccharides and polysaccharide producing cultures for use in fermented dairy products depends on many factors, such as the functionality of the polysaccharide produced, the type of product, and the production process. For example, in the context of the present invention, a suitable polysaccharide must achieve the desired water-holding capacity and also meet other criteria to be commercially useful. Importantly, polysaccharides that result in high texture are not suitable for the production of cheeses such as Mozzarella. Therefore, suitable polysaccharides must combine high water-holding capacity with relatively low shear stress to avoid viscous whey during the cheese-making process, which is problematic. Furthermore, the strains producing such polysaccharides must be able to acidify milk relatively quickly, i.e., they must be able to reach a pH of 4.5 quickly during fermentation. Slow fermentation leads to long waiting times, high costs, and a high possibility of contamination with undesirable microorganisms.
[0008] Exopolysaccharides are produced either as unattached material excreted into the environment (often called extracellular polysaccharides (EPS)) or as capsules attached to the bacterial surface (called capsular polysaccharides or CPS) (Zeidan et al., 2017). CPS are more suitable for cheesemaking applications because they have a lower tendency to increase whey viscosity compared to rope-like EPS (Awad et al., 2005; Broadbent et al., 2001). Rope-like EPS is less desirable in cheesemaking due to increased whey viscosity. The gene clusters encoding the enzymes responsible for the production of exopolysaccharides are commonly referred to as eps gene clusters. Summary of the Invention [Problem to be solved by the invention]
[0009] The art taught that excreted EPS was not suitable for achieving the desired combination of high water-holding capacity and low viscosity. Instead, CPS should be used (Low et al., 1998; Broadbent et al., 2001). Although it is not yet fully understood which specific structures of CPS or EPS could achieve the desired combination of water-holding capacity and low viscosity, there was a strong motivation to investigate additional strains that produce CPS and avoid EPS. [Means for solving the problem]
[0010] The inventors have surprisingly discovered that the strains that primarily produce the excreted EPS structures of the present invention exhibit both desirable high water-holding capacity and low shear stress. The inventors have also identified the corresponding eps gene clusters, elucidated the structure of the repeating units of such polysaccharides, and provided strains that produce exopolysaccharides that combine desirable levels of water-holding capacity and texture while maintaining fast acidification rates.
[0011] The exopolysaccharide structure of the present invention has not been reported before. Moreover, the presence of EPS and the existence of bacterial strains producing such EPS that can combine all the desired properties of water holding capacity, relatively low shear stress and acidification rate was not evident from the prior art, prompting the search for additional strains that primarily produce CPS to achieve the desired result.
[0012] The invention also relates to compositions and starter cultures comprising such exopolysaccharides and / or strains, as well as methods of using the exopolysaccharides and / or strains for the production of food products, and food products comprising the exopolysaccharides and / or strains.
[0013] Brief Description of the Sequence Listing SEQ ID NO:1 shows the complete sequence of the eps gene cluster of S. thermophilus strain DSM33981 (or a mutant thereof). SEQ ID NO:2 shows the complete sequence of the eps gene cluster of S. thermophilus strain DSM33982 (or a mutant thereof). [Brief description of the drawings]
[0014] [Figure 1] FIG. 1 shows the repeating unit structure of the polysaccharide produced by DSM33981.
[0015] [Diagram 2] FIG. 2 shows the repeating unit structure of the polysaccharide produced by DSM33982. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0016] definition All definitions of terms related to this specification are as understood by a person of ordinary skill in the art in the context of the technical aspects related to this specification.
[0017] In the context of the present invention, in any of its embodiments, the expression "lactic acid bacteria" ("LAB") refers to food-grade bacteria that produce lactic acid as the main metabolic end product of carbohydrate fermentation. These bacteria are related by common metabolic and physiological properties and are gram-positive, low GC, acid-tolerant, non-spore-forming, bacilli or cocci. During the fermentation stage, the consumption of carbohydrates by these bacteria leads to the formation of lactic acid, which decreases the pH and leads to the formation of protein coagulum. These bacteria are therefore involved in the acidification of milk and the texture of dairy products. The S. thermophilus strain of the present invention is classified as a lactic acid bacteria.
[0018] In the present specification and claims, a "water-retaining strain" refers to a strain which preferably produces fermented milk with a water-retaining capacity of 85% or more, more preferably 88% or more or 91% or more, expressed as the percentage of curd remaining in the sample after centrifugation and removal of whey, under the conditions described below and exemplified in Example 1. For example, the water-retaining capacity may be 85-100%, 85-95%, or 85-90%. The strain exemplified in Example 1 has a water-retaining capacity of 88-91%.
[0019] The water-retaining strain of the present invention may be any bacterial strain. The strain of the present invention may be an isolated strain, e.g. isolated from a natural source, or a non-naturally occurring strain, e.g. obtained by recombinant means. A recombinant strain differs from a naturally occurring strain at least in the presence of a nucleic acid construct used to transform or transfect the parent strain. According to a preferred embodiment of the present invention, the water-retaining strain of the present invention is a lactic acid bacterium. According to a most preferred embodiment of the present invention, the water-retaining strain is a S. thermophilus strain.
[0020] "Water holding capacity" is an important factor for the production efficiency of fermented milk products. The texture of fermented milk depends on both the bacteria used for fermentation and the process parameters. Extracellular polysaccharides produced by bacteria can have a positive effect on water holding capacity.
[0021] Several methods have been implemented to measure the water-holding capacity of fermented milk, including centrifugation, siphoning, drainage, and nuclear magnetic resonance (NMR) ( Amatayakul et al., 2006 ; Gilbert et al., 2020 ).
[0022] Centrifugation, used to estimate the water trapped in the matrix, appears to be the most commonly used method to quantify water-holding capacity. The centrifugation method measures the level of whey separated from the collapsed gel as a result of the applied high external force (centrifugal force), i.e. the resistance of the gel to compression.
[0023] In the present invention, "water holding capacity" is measured by centrifugation and is expressed as the percentage of curd remaining in a sample after centrifugation and removal of whey.
[0024] "Texture" is also an important quality factor of fermented milk products and consumer acceptance is often closely linked to the textural properties. The texture of fermented milk depends on the exopolysaccharide structure, the bacteria used for fermentation, the process parameters and the milk composition. In the context of the present invention, the rheological properties (texture) of fermented milk products, such as viscosity, can be measured as a function of shear stress of the fermented milk product, as explained below.
[0025] In the context of the present invention, "shear stress" can be measured by the following method: When the pH of the fermented milk (e.g. of mammalian or plant origin) has reached, for example, a pH of about 4.55 at an incubation temperature of 40°C, the container is transferred to ice water to cool the fermented milk product. The fermented milk sample is gently stirred manually with a rod fitted with a perforated disk until the sample is homogenous. The rheological properties of the samples were evaluated in a rheometer (ASC, Anton Paar Physica Rheometer with automatic sample changer, Anton Paar® GmbH, Austria) using a bob cup. During the measurements, the rheometer was set at a constant temperature of 13°C. The settings were as follows: - Retention time (to restore some of the original structure) - 5 minutes without subjecting the sample to any physical stress (vibration or rotation). - Vibration process (measure the elastic modulus G' and the viscous modulus G'' respectively and calculate the complex modulus G*) Constant distortion = 0.3 %, frequency (f) = [0.5...8] Hz 6 measurement points over 60 seconds (1 every 10 seconds) - Rotation process (shear stress measured at 3001 / s) - Two processes were designed: - 1) shear rate = [0.3-300] 1 / s, and 2) shear rate = [275-0.3]1 / s. Each step included 21 measurement points over 210 seconds (every 10 seconds). The shear stress of 3001 / s (300s-1) was chosen for further analysis because it correlates with the mouth thickness when swallowing fermented dairy products.
[0026] Strains capable of acidifying milk within approximately 8 hours are sometimes called "fast-acidifying" strains, i.e. strains that reach a pH of approximately 4.55 within 8 hours, as measured as follows: 200 mL of semi-fat milk (1.5% fat) is heated to 90°C for 20 minutes, then cooled to the inoculation temperature, inoculated with 2 mL of an overnight culture of the lactic acid bacteria strain, and allowed to stand until the pH reaches 4.55 at the inoculation temperature. The inoculation temperature is 40°C.
[0027] The term "sequence identity" relates to the relatedness between two nucleotide sequences or two amino acid sequences. For the purposes of the present invention, the degree of sequence identity between two nucleotide sequences or two amino acid sequences is determined, for example, using the multiple sequence alignment tool Clustal Omega (https: / / www.ebi.ac.uk / Tools / msa / clustalo / ; Sievers et al., 2011) with standard parameters.
[0028] In this context, the terms "strains derived from", "derived strain" or "mutant" are to be understood as strains derived from the strain of the invention, for example by genetic engineering, radiation and / or chemical treatment, and / or selection, adaptation, screening, etc. Derivative strains are preferably functionally equivalent mutants, for example strains having substantially the same or improved properties as the parent strain with respect to water-holding capacity. Such derived strains are part of the present invention. In particular, the terms "derived strain" or "mutant" refer to strains obtained by subjecting the strain of the invention to any conventionally used mutagenesis treatment, including treatment with chemical mutagens such as ethanemethanesulfonic acid (EMS) or N-methyl-N'-nitro-N-nitroguanidine (NTG), UV light, or spontaneous mutations.
[0029] The mutants may have been subjected to multiple mutagenesis treatments (a single treatment should be understood as one mutagenesis step followed by a screening / selection step), although it is currently preferred that no more than 20, no more than 10, or no more than 5 treatments are performed. In currently preferred derivatives, less than 1%, or less than 0.1%, or less than 0.01%, or less than 0.001%, or less than 0.0001% of the nucleotides of the bacterial genome have been altered (such as by substitution, insertion, deletion, or a combination thereof) compared to the parent strain.
[0030] In the present specification, the terms "fermented milk" and "dairy" are used interchangeably. In the context of the present invention, in any of its embodiments, the expression "fermented milk product" refers to a food or feed product comprising a milk-based fermentation by lactic acid bacteria. As used herein, "fermented milk product" includes, but is not limited to, products such as thermophilic fermented milk products or mesophilic fermented milk products. The term "thermophilic fermentation" herein refers to fermentation at temperatures above about 35°C, for example at temperatures between about 35°C and about 45°C. The term "mesophilic fermentation" herein refers to fermentation at temperatures between about 22°C and about 35°C.
[0031] In the context of this application, the term "milk" is used broadly in its general sense and refers to the liquid produced by the mammary gland of an animal (e.g., cow, sheep, goat, buffalo, camel, etc.) or the liquid produced using a plant base. The term "milk base" or "milk substrate" can be any milk material that can be fermented according to the present invention. Useful milk bases thus include, but are not limited to, whole or low-fat milk, skim milk, buttermilk, reconstituted milk powder, condensed milk, dry milk, whey, whey permeate, lactose, mother liquor from lactose crystallization, whey protein concentrate, cream, or any milk or milk-like product solution / suspension containing protein, such as plant-based milk. The milk base can be of any mammalian origin, e.g., substantially pure mammalian milk, or reconstituted milk powder. Plant sources of milk include, but are not limited to, milk extracted from soybeans. Preferably, the plant-based milk is soy milk, which may preferably be supplemented with glucose, such as 0.5-5% glucose, preferably 0.5-2% glucose, more preferably about 2% glucose.
[0032] Prior to fermentation, the milk base may be homogenized and pasteurized according to methods known in the art.
[0033] In the context of the present invention, "Homogenizing" as used in any of its embodiments means intensive mixing to obtain a soluble suspension or emulsion. If homogenization is performed before fermentation, it may be performed to break down the milk fat into smaller sizes so that the milk fat does not separate from the milk. This may be achieved by forcing the milk through small openings under high pressure.
[0034] In the context of the present invention, "Pasteurizing" as used in any of its embodiments means the treatment of a milk base to reduce or eliminate the presence of live organisms, such as microorganisms. Pasteurization is preferably achieved by maintaining a specified temperature for a specified time. The specified temperature is usually achieved by heating. The temperature and duration can be selected to kill or inactivate specific bacteria, such as harmful bacteria. This may be followed by a rapid cooling step.
[0035] "Fermentation" in the context of the present invention means, in any embodiment, the conversion of carbohydrates into acids or alcohols or a mixture of both by the action of microorganisms (LAB). The fermentation processes used in the production of food products such as dairy products are well known and the skilled person will know how to select the appropriate process conditions such as temperature, oxygen, amount of microorganisms and process time. The fermentation conditions are selected to support the achievement of the present invention, for example to obtain a food product, preferably a food product with improved water holding capacity, compared to a food product produced by a method that does not use an EPS structure as described in the first aspect of the invention and / or at least one strain that produces such a structure, or a method that does not use a composition as described in the second aspect of the invention in any of its embodiments.
[0036] The term "dairy product" as used herein refers to food products made from milk. As mentioned above, in the context of this application, the term "milk" is used broadly in its general sense and refers to the liquid produced by the mammary glands of animals (e.g., cows, sheep, goats, buffalo, camels, etc.) or plants. According to a preferred embodiment, the milk is cow's milk. According to the present invention, the milk may be processed and the term "milk" includes whole milk, skim milk, nonfat milk, low-fat milk, full-fat milk, lactose-reduced milk, or concentrated milk. Nonfat milk is nonfat milk or skim milk products. Low-fat milk is typically defined as milk containing about 1% to about 2% fat. Full-fat milk often contains 2% or more fat. The term "milk" is intended to encompass milk from a variety of mammalian and plant sources. Mammalian sources of milk include, but are not limited to, cows, sheep, goats, buffalo, camels, llamas, mares, and deer. Milk from plant sources includes, but is not limited to, milk extracted from soybeans, peas, peanuts, barley, rice, oats, quinoa, almonds, cashews, coconuts, hazelnuts, hemp, sesame, and sunflower seeds. In a particular embodiment, the milk is cow's milk. According to another particular embodiment, the milk is a plant-based milk, preferably soy milk, which may be supplemented with glucose, for example 0.5-5% glucose, preferably 0.5-2% glucose, more preferably about 2% glucose.
[0037] The term "about" (or "around") as used herein means the indicated value ±1% of that value, or the term "about" means the indicated value ±2% of that value, or the term "about" means the indicated value ±5% of that value, or the term "about" means the indicated value ±10% of that value, or the term "about" means the indicated value ±20% of that value, or the term "about" means the indicated value ±30% of that value. Preferably, the term "about" means the exact indicated value (±0%).
[0038] Throughout the present description and claims, the word "comprise" and its variations (such as "comprising", "having", "including", "containing", etc.) are generally not limiting and therefore do not exclude other features, such as technical features, additives, components, or steps. However, whenever the word "comprise" is used herein, specific embodiments in which this word is understood to be limiting are also included. According to this specific embodiment, the word "comprise" has the meaning of the term "consisting of".
[0039] In the context of describing the present invention (particularly in the context of the claims below), the use of the terms "a" and "an" and "the" and similar referents are to be construed to include both the singular and the plural, unless otherwise indicated herein or clearly contradicted by context. The recitation of ranges of values herein is intended merely as a shorthand method of referring individually to each individual value falling within the range, unless otherwise indicated herein, and each individual value is incorporated into the specification as if it were individually set forth herein. All methods described herein can be performed in any suitable order, unless otherwise indicated herein or clearly contradicted by context.
[0040] Any examples provided herein, or the use of exemplary language (e.g., "such as"), are intended merely to more clearly illustrate the invention and do not limit the scope of the invention unless specifically claimed. No language in the specification should be construed as indicating any non-claimed element as essential to the practice of the invention.
[0041] Exopolysaccharide structure and eps gene cluster of S. thermophilus strains The aim of the present invention is to provide structures of exopolysaccharides produced by S. thermophilus strains, which contribute to improved water-holding capacity, suitable for food production. The inventors have also analyzed the corresponding eps gene clusters and identified gene sequences involved in the production of the exopolysaccharides of the present invention. These exopolysaccharides are responsible for the excellent water-holding capacity and relatively low shear stress, which are desirable for the production of cheeses such as mozzarella. As shown in Example 1, strains producing such exopolysaccharides (DSM33981 and DSM33982) produce fermented milk with excellent water-holding capacity.
[0042] The DSM33981 strain has the eps gene cluster of SEQ ID NO:1 and produces a polysaccharide with the repeating unit as shown in Figure 1. The DSM33982 strain has the eps gene cluster of SEQ ID NO:2 and produces a polysaccharide with the repeating unit as shown in Figure 2.
[0043] These polysaccharide producing strains preferably have 95% or more sequence identity to the listed eps gene clusters, e.g., 95%, 96%, 97%, 98%, or 99%. Most preferably, the sequences have 100% identity.
[0044] LAB have been shown to produce exopolysaccharides by two pathways encoded by different genome components: the sucrase-dependent pathway and the Wzy-dependent pathway (Zeidan et al., 2017). S. thermophilus lacks the sucrose-dependent pathway and synthesizes exopolysaccharides exclusively by the Wzy-dependent pathway, encoded here in a gene cluster called the eps cluster (Zeidan et al., 2017). In general, the eps cluster consists of regions of well-conserved genes flanking variable regions of biosynthetic genes encoding glycosyltransferases. This variability underlies the diversity of polysaccharide structures, with glycosyltransferases responsible for building the repeating units that are then assembled into long polymers. The repeating units are synthesized intracellularly and the nascent glycosides are anchored in lipid membranes. The first step of the process is catalyzed by a priming glycosyltransferase, which primes the sugar monomer by attaching it to a lipid anchor, usually undecaprenyl phosphate (Islam et al., 2014). After the first sugar monomer is attached, glycosyltransferases encoded by the eps cluster sequentially add the remaining sugar monomers to complete the entire repeating unit.
[0045] Once a repeat unit is completed, it is flipped to the outside of the cell membrane and added to the growing chain of repeat units by polymerase ( Islam et al., 2014 ).
[0046] This structure is thought to influence the differences in water-holding capacity of various LAB strains.
[0047] Compositions Comprising Exopolysaccharides and / or S. thermophilus Strains Producing Such Exopolysaccharides The present invention also provides compositions and starter cultures comprising the described exopolysaccharides and / or S. thermophilus strains of the invention.
[0048] LAB containing bacteria of the species S. thermophilus are usually supplied to the dairy industry as frozen (F-DVS) or freeze-dried (FD-DVS) cultures for bulk starter growth or as so-called "direct vat set" (DVS) cultures intended for direct inoculation of fermentation vessels or vats for the production of dairy products, such as fermented dairy products. Such lactic acid bacteria cultures are commonly called "starter cultures" or "starters". The compositions of the invention may therefore be frozen or freeze-dried. Furthermore, the compositions of the invention may be provided in liquid form. Thus, according to one embodiment, the compositions are in frozen, dried, freeze-dried or liquid form.
[0049] The composition or starter culture of the present invention may additionally comprise a cryoprotectant, a cryoprotectant, an antioxidant, a nutrient, a filler, a flavoring, or a mixture thereof. Preferably, the composition comprises one or more of a cryoprotectant, a cryoprotectant, an antioxidant, and / or a nutrient, more preferably a cryoprotectant, a cryoprotectant, and / or an antioxidant, and most preferably a cryoprotectant or a cryoprotectant, or both. The use of cryoprotectants and protective agents such as cryoprotectants is known to those skilled in the art. Suitable cryoprotectants or lyoprotectants include mono-, di-, tri- and polysaccharides (such as glucose, mannose, xylose, lactose, sucrose, trehalose, raffinose, maltodextrin, starch and gum arabic (acacia)), polyols (such as erythritol, glycerol, inositol, mannitol, sorbitol, threitol, xylitol), amino acids (such as proline, glutamic acid), complex substances (such as skim milk, peptone, gelatin, yeast extract), and inorganic compounds (such as sodium tripolyphosphate).
[0050] According to one embodiment, the composition or starter culture according to the invention may comprise one or more cryoprotectants selected from the group consisting of inosine-5'-monophosphate (IMP), adenosine-5'-monophosphate (AMP), guanosine-5'-monophosphate (GMP), uranosine-5'-monophosphate (UMP), cytidine-5'-monophosphate (CMP), adenine, guanine, uracil, cytosine, adenosine, guanosine, uridine, cytidine, hypoxanthine, xanthine, hypoxanthine, orotidine, thymidine, inosine, and derivatives of these compounds. Suitable antioxidants include ascorbic acid, citric acid and its salts, gallic acid, cysteine, sorbitol, mannitol, maltose. Suitable nutrients include sugars, amino acids, fatty acids, minerals, trace elements, vitamins (such as B vitamins, vitamin C, etc.). The composition may optionally contain further substances such as fillers (lactose, maltodextrin etc.) and / or flavourings.
[0051] According to one embodiment of the invention, the cryoprotectant is a drug or mixture of drugs that has a booster effect in addition to the cryoprotective function.
[0052] The expression "booster effect" is used to describe the situation where a cryoprotectant induces increased metabolic activity in a thawed or reconstituted culture when it is inoculated into a fermentation or transformation medium. Viability and metabolic activity are not synonymous. Commercially available frozen or lyophilized cultures may have lost a significant portion of their metabolic activity, but viability may be retained. For example, cultures may lose acidogenic (acidification) activity even during short storage periods. Thus, viability and booster effect need to be evaluated by different assays. Whereas viability is evaluated by viability assays such as the measurement of colony forming units, booster effect is evaluated by quantifying the relevant metabolic activity of the thawed or reconstituted culture in comparison to the viability of the culture. The term "metabolic activity" refers to the oxygen scavenging activity of the culture, its acid-producing activity, i.e. the production of, for example, lactic acid, acetic acid, formic acid and / or propionic acid, or its metabolic product-producing activity, for example the production of aroma compounds such as acetaldehyde, (α-acetolactate, acetoin, diacetyl and 2,3-butylene glycol (2,3-butanediol)).
[0053] According to one embodiment, the composition or starter culture of the invention comprises 0.2-20% of the cryoprotectant or mixture of drugs measured as a % by weight of the material. However, it is preferred to add the cryoprotectant or mixture of drugs in an amount ranging from 0.2-15%, 0.2-10%, 0.5-7%, and 1-6% by weight, including within the range of 2-5% of the cryoprotectant or mixture of drugs measured as a % by weight of the frozen material. According to a preferred embodiment, the culture comprises about 3% of the cryoprotectant or mixture of drugs measured as a % by weight of the material. An amount of about 3% of the cryoprotectant corresponds to a concentration in the range of 100 mM. It should be appreciated that for each aspect of the embodiment of the invention, the ranges may be increments of the stated ranges.
[0054] According to a further aspect, the composition or starter culture of the invention comprises or comprises an ammonium salt (e.g. an ammonium salt of an organic acid (e.g. ammonium formate and ammonium citrate) or an ammonium salt of an inorganic acid) as a booster (e.g. a growth booster or acidification booster) for bacterial cells, such as cells belonging to the species S. thermophilus, such as (substantially) urease negative bacterial cells. The terms "ammonium salt", "ammonium formate" and the like should be understood as a source of a combination of salts or ions. The term "source" of, for example, "ammonium formate" or "ammonium salt" refers to a compound or a mixture of compounds that provides ammonium formate or an ammonium salt when added to the cell culture. According to some embodiments, the ammonium source releases ammonium into the growth medium, according to other embodiments, the ammonium source is metabolized to produce ammonium. According to some preferred embodiments, the ammonium source is exogenous. According to some particularly preferred embodiments, the ammonium is not provided by the dairy substrate. Of course, it should be understood that ammonia may be added instead of an ammonium salt. Thus, the term ammonium salt refers to ammonia (NH3), NH4OH, NH4 + etc.
[0055] According to one embodiment, the compositions of the present invention may include thickeners and / or stabilizers such as pectin (e.g., HM pectin, LM pectin), gelatin, CMC, soy fiber / soy polymers, starch, modified starch, carrageenan, alginates, and guar gum.
[0056] Methods for producing food or feed products The present invention further relates to a method for producing a food product comprising at least one step using at least one exopolysaccharide and / or S. thermophilus strain as defined in the first aspect of the invention and / or a composition or a starter culture as defined in the second aspect of the invention. The production of the food product is carried out by methods known to the person skilled in the art.
[0057] According to one aspect, the present invention relates to a method for producing a food product comprising at least one step in which at least one of the exopolysaccharides of the present invention is used.
[0058] According to another embodiment, the present invention relates to a method for producing a food product comprising at least one step using the lactic acid bacteria strain S. thermophilus DSM 33981 or a mutant or variant thereof.
[0059] According to another embodiment, the present invention relates to a method for producing a food product comprising at least one step using the lactic acid bacteria strain S. thermophilus DSM 33982 or a mutant or variant thereof.
[0060] For example, the method of the present invention can be used to 6 CFU / mL, preferably at least 1x10 8 The method comprises fermenting a milk substrate with a composition comprising at least one CFU / mL of S. thermophilus strain DSM33981 or a mutant or variant thereof.
[0061] For example, the method of the present invention can be used to 6 CFU / mL, preferably at least 1x10 8 The method comprises fermenting a milk substrate with a composition comprising at least one CFU / mL of S. thermophilus strain DSM33982 or a mutant or variant thereof.
[0062] According to another preferred embodiment, the method comprises fermenting a dairy substrate with a composition as described in any embodiment of the second aspect of the invention.
[0063] Preferably, the food product is a dairy product and the method, in any of its embodiments, comprises fermenting a dairy substrate (also referred to in the context of the present invention as "dairy base") with at least one S. thermophilus and / or composition or starter culture according to the present invention.
[0064] Preferably, the food product is a dairy product and the method in any embodiment comprises fermenting a plant-based milk substrate (also referred to in the context of the present invention as a "plant-based milk base"), such as soy milk, preferably soy milk supplemented with glucose (e.g. 0.5-5% glucose, preferably 0.5-2% glucose, more preferably about 2%), with at least one S. thermophilus strain and / or a composition or starter culture according to the invention (first and second aspects respectively).
[0065] The food products according to the invention may advantageously further comprise "thickeners" and / or "stabilizers" such as pectin (e.g. HM pectin, LM pectin), gelatin, CMC, soy fibre / soy polymers, starch, modified starch, carrageenan, alginates and guar gum.
[0066] According to certain embodiments, the food product is a dairy product, a meat product, a vegetable product, a fruit product or a cereal product. According to a preferred embodiment, the food product is a dairy product as defined above. According to another preferred embodiment, the food product is a plant-based food product, such as fermented soy milk.
[0067] According to a particular embodiment of the invention, the fermented milk product is selected from the group consisting of mozzarella cheese, yogurt, kefir, sour cream, cheese, quark. Mozzarella is particularly preferred. According to a preferred embodiment of the invention, the fermented milk product comprises a further food product selected from the group consisting of fruit drinks, cereal products, fermented cereal products, chemically acidified cereal products, soy milk products, fermented soy milk products, and mixtures thereof. According to another preferred embodiment, the fermented milk product is a plant-based fermented milk product, such as fermented soy milk.
[0068] Fermented milk products usually contain 1.0-12.0% by weight, preferably 2.0-10.0% by weight of protein. According to a particular embodiment, sour cream contains 1.0-5.0% by weight, preferably 2.0-4.0% by weight of protein. According to a particular embodiment, quark contains 4.0-12.0% by weight, preferably 5.0-10.0% by weight of protein.
[0069] Preferably, the food product has improved water holding capacity compared to a food product produced by a comparable method that does not use a S. thermophilus strain having an active eps gene cluster described in the present invention, at least one EPS, and / or does not use the described composition or starter culture (such as Example 1 described in the present invention).
[0070] Unless otherwise indicated herein or clearly contradicted by context, any combination of the above-described elements, aspects, and embodiments in all possible variations thereof is encompassed by the invention. Embodiments of the invention are described below by way of example only. EXAMPLES
[0071] Example 1: Evaluation of the water-holding capacity of fermented milk using S. thermophilus strains producing desired exopolysaccharides. Overnight cultures grown in M17 broth containing 2% lactose were used for milk acidification (1% inoculum) in stimulant-treated skim milk (SHT-SM) for shear stress measurements and pasteurized low-fat milk (past-LFM) for water-holding capacity measurements (e.g., for Mozzarella cheese applications). SHT-SM was prepared by reconstitution of skim milk powder containing 38% protein, 53% lactose, and S. thermophilus (Derzelle, Bolotin, Mistou, & Rul, 2005).
[0072] Water holding capacity was measured by centrifugation and expressed as the percentage of curd remaining in the sample after centrifugation and whey removal.
[0073] Pasteurized low-fat milk from Arla, containing 1.5% fat and 3.8% protein, was pasteurized at 90°C for 20 min, cooled to 40°C, and supplemented with 0.003% Na to stimulate the growth of S. thermophilus. + -Formic acid (HCOONa) was added.
[0074] Weigh a sterile, empty plastic bottle and fill it with 1% overnight culture and 0.003% Na + -200 mL of pasteurized low-fat milk containing formic acid was added. Samples were incubated at 40°C until pH 4.55, then cooled in ice water for 30 min and left at 4°C overnight. Samples were centrifuged at 2325xg for 3 min and the whey was carefully poured out of the plastic bottles. Samples were weighed before and after whey removal. Water holding capacity (WHC) was expressed as the percentage of curd remaining in the sample after whey removal. Each sample was run in four replicates, one for monitoring the milk acidification using a pH electrode and the remaining three for measuring water holding capacity.
[0075] [Table 1]
[0076] Two exemplary strains carrying the desired eps gene clusters producing the claimed exopolysaccharide structures clearly demonstrate the combination of high water-holding capacity and low shear stress.
[0077] Example 2: Evaluation of EPS and CPS production in S. thermophilus strains. Polysaccharide fractions were purified by ethanol precipitation from samples collected at the stationary phase of growth and quantified by the phenol-sulfuric acid method to determine the total sugar content. Growth was carried out under anaerobic conditions in chemically defined medium supplemented with 2% lactose (CDMLac), at a constant pH of 6.5 and 40°C. The pH was kept constant by addition of NaOH. Values are the mean ± standard deviation of at least five technical replicates.
[0078] [Table 2]
[0079] The strain of the embodiment mainly produces the excreted EPS of the present invention. It was previously believed that an increase in the amount of EPS would necessarily lead to an increase in viscosity, i.e., a higher shear stress. The EPS of the claimed structure can combine both high water retention capacity and relatively low shear stress (Example 1).
[0080] Example 3: Determination of extracellular polysaccharide structure The strain was cultivated in a chemically defined medium under anaerobic conditions at 40 °C for 24 h. The culture was then centrifuged (10,000xg, 1 h, 4 °C) and the supernatant was treated with trichloroacetic acid 80% (w / v) to a final concentration of 20%. Precipitation was allowed to proceed for 2 h at 4 °C with stirring. The mixture was centrifuged (10,000xg, 1 h, 4 °C) and the crude EPS was precipitated by adding an equal volume of acetone (4 °C) to the supernatant. After overnight precipitation at 4 °C with gentle stirring, the sample was centrifuged (10,000xg, 1 h, 4 °C). The pellet was washed three times with 50% acetone (4 °C) and the resulting pellet was suspended in 50 mL of distilled water with vigorous stirring. The suspension was sonicated for 5 min to obtain a clear solution. Finally, the solution was dialyzed against distilled water (5 L) at 4 °C for 12 h. Dialysis was repeated a total of three times, each against fresh distilled water. The contents of the dialysis bag were lyophilized, and the EPS residue was dissolved in 1 mL of DO by vigorous mixing and sonication.
[0081] For structure elucidation by NMR, spectra were acquired on an AVANCE III 800 spectrometer (Bruker, Rheinstetten, Germany) equipped with a three-channel inverse detector probe (TXI) with pulse field gradients and operating at a proton operating frequency of 800.33 MHz. Two-dimensional spectra for structure elucidation were acquired at 60oC using the standard pulse program from Bruker. To fully assign all resonances in the HSQC map, proton homonuclear shift correlation spectroscopy (COSY), total correlation spectroscopy (TOCSY), 1 H- 13 C multiplicity-edited heteronuclear single quantum coherence spectroscopy (ed-HSQC) and 2D HSQC-TOCSY were used. 3 J H1、H2 The configuration of the sugar ring was established using 1JC, H1 measured from the unresolved HSQC spectrum. Heteronuclear multiple bond connection spectra (HMBC) were obtained to determine the location of the glycosidic bond. The identity of the sugar monomer was confirmed by 1 H and 13 C chemical shift patterns and, where possible, unambiguous 3 J H、H This was also established by coupling determination.
[0082] [Table 3]
[0083] Example 4: Determination of the eps gene cluster Because eps clusters have conserved genes at both ends, they were identified using BLAST by searching the translated gene sequences of annotated genomes for known protein sequences of the first and last genes of the cluster. The organization of genes in the eps clusters of LAB reviewed by Zeidan et al. (2017) was used to determine the first and last eps genes of individual species (e.g., epsA and orf14.9 in S. thermophilus). When a single hit with >90% sequence identity and >90% coverage was found in both the first and last gene, all genes between and including the two hits were extracted and used as the eps cluster.
[0084] Deposit Streptococcus thermophilus strain DSM33981 was deposited at DSMZ (Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbFI, Inhoffenstr. 7B, D-38124 Braunschweig, Germany) on August 18, 2021 under the accession number DSM33981.
[0085] Streptococcus thermophilus strain DSM33982 was deposited at DSMZ (Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbFI, Inhoffenstr. 7B, D-38124 Braunschweig, Germany) on August 18, 2021 under the accession number DSM33982.
[0086] The deposit was made under the terms of the Budapest Treaty on the International Recognition of the Deposit of Microorganisms for the Purposes of Patent Procedure. The applicant requests that samples of the deposited microorganisms be provided only to experts approved by the applicant.
[0087] References Amatayakul, T., Sherkat, F. and Shah, NP (2006). Syneresis in set yoghurt as affected by EPS starter cultures and level of solids. International Journal of Dairy Science, 59, 3, 216-221. https: / / doi.org / 10.1111 / j.1471-0307.2006.00264.x Awad, S., Hassan, AN and Muthukumarappan, K. (2005). Application of Exopolysaccharide-Producing Cultures in Reduced-Fat Cheddar Cheese: Texture and Melting Properties. Journal of Dairy Science, 88, 12, 4204-4213. https: / / doi.org / 10.3168 / jds.S0022-0302(05)73106-4 Broadbent, JR, McMahon, DJ, Oberg, CJ and Welker, DL (2001). Use of exopolysaccharide-producing cultures to improve the functionality of low fat cheese. International Dairy Journal, 11, 4-7, 433-439. https: / / doi.org / 10.1016 / S0958-6946(01)00084-X Gilbert, A., Rioux, LE, St-Gelais, D., and Turgeon, SL (2020). Characterization of syneresis phenomena in stirred acid milk gel using low frequency nuclear magnetic resonance on hydrogen and image analyses. Food Hydrocolloids. 106. https: / / doi.org / 10.1016 / j.foodhyd.2020.105907 Islam, ST, and Lam, JS (2014). Synthesis of bacterial polysaccharides via the Wzx / Wzy-dependent pathway. Canadian Journal of Microbiology, 60(11), 697-716. https: / / doi.org / 10.1139 / cjm-2014-0595 Low, D., Ahlgren, JA, Horne, D., McMahon, DJ, Oberg, CJ, and Broadbent, JR (1998). Role of Streptococcus thermophilus MR-1C capsular exopolysaccharide in cheese moisture retention. Applied Environmental Microbiology, 64, 6, 2147-2151. https: / / doi.org / 10.1128 / AEM.64.6.2147-2151.1998 Sievers, F., Wilm, A., Dineen, D., Gibson, T., Karplus, K., Weizhong, L., Lopez, R., McWilliam, H., Remmert, M., Soding, J., Thompson, J., and Higgins, DG (2011). Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega. Mol. Syst. Biol., 7:539. https: / / doi.org / 10.1038 / msb.2011.75 Zeidan, AA, Poulsen, VK, Janzen, T., Buldo, P., Derkx, PMF, Oregaard, G., and Neves, AR (2017). Polysaccharide production by lactic acid bacteria: from genes to industrial applications. FEMS Microbiology Reviews, 41(1), S168-S200. https: / / doi.org / 10.1093 / femsre / fux017
Claims
1. A polysaccharide having a repeating unit structure, the backbone of which is composed of rhamnose, galactose, glucose, and N-acetylglucosamine in a 2:2:1:1 ratio, with rhamnose optionally being O-acetylated.
2. 2. The polysaccharide of claim 1, wherein the main chain of the repeating unit structure is a linear hexamer, optionally including at least one side branch having at least one sugar.
3. The repeating unit structure: (i) 【Chemistry 1】 or (ii) 【Chemistry 2】 3. The polysaccharide according to claim 1 or 2, having the formula:
4. A lactic acid bacteria strain comprising an active eps gene cluster producing a polysaccharide according to any one of claims 1 to 3, said eps gene cluster having at least 95% sequence identity with SEQ ID NO: 1 or SEQ ID NO:
2.
5. The lactic acid bacteria strain according to claim 4, wherein the lactic acid bacteria strain is a S. thermophilus bacterium.
6. The lactic acid bacteria strain is (i) DSM33981, (ii) DSM33982, or a mutant thereof having retained or further improved water-holding capacity.
7. A composition comprising a polysaccharide according to any one of claims 1 to 3 and / or at least one lactic acid bacteria strain according to any one of claims 4 to 6.
8. A starter culture comprising at least one of the polysaccharides according to any one of claims 1 to 3, the lactic acid bacteria strain according to claims 4 to 6, and / or the composition according to claim 7.
9. Use of a polysaccharide according to any one of claims 1 to 3, a lactic acid bacteria strain according to claims 4 to 6, a composition according to claim 7 and / or a starter culture according to claim 8 for regulating the water holding capacity of a fermented product.
10. 10. A method for producing a food or feed product, comprising at least one step using at least one of the polysaccharides according to any one of claims 1 to 3, the lactic acid bacteria strains according to claims 4 to 6, the composition according to claim 7, and / or the starter culture according to claim 8.
11. 11. The method of claim 10, wherein the food product is a cheese, such as mozzarella, yogurt, kefir, sour cream, or quark, and optionally further comprising the step of using additional lactic acid bacteria.
12. 10. A food or feed product comprising at least one of the polysaccharides according to any one of claims 1 to 3, the lactic acid bacteria strain according to claims 4 to 6, the composition according to claim 7, and / or the starter culture according to claim 8.
13. 13. The food or feed product of claim 12, wherein the food or feed product is a dairy product, including fermented plant-based milk and / or mammalian milk.
14. 14. The food or feed product of claim 13, wherein the food product is mozzarella cheese.
15. A method for producing the lactic acid bacteria strain according to claim 4, comprising using the deposited strain as starting material, screening the eps gene cluster and obtaining mutant strains by selecting bacteria which retain the eps gene cluster.
